Why the Pharmaceutical Industry Needs Implementation Science for Sustainable Innovation.
作者信息
Messina Anthony J
机构信息
RTI Health Solutions, 3040 E. Cornwallis Rd, Durham, NC, 27713, USA.
出版信息
Pharmaceut Med. 2025 May;39(3):147-150. doi: 10.1007/s40290-025-00566-x.
Abstract
摘要
相似文献
1
Why the Pharmaceutical Industry Needs Implementation Science for Sustainable Innovation.制药行业为何需要实施科学以实现可持续创新。
Pharmaceut Med. 2025 May;39(3):147-150. doi: 10.1007/s40290-025-00566-x.
2
The impact of the Drug Marketing Authorization Holder system on sustainable improvement of innovation quality in the pharmaceutical manufacturing industry in China-An empirical study using synthetic control methods.《药品上市许可持有人制度对中国制药行业创新质量可持续提升的影响——基于合成控制法的实证研究》
PLoS One. 2024 Jul 5;19(7):e0304056. doi: 10.1371/journal.pone.0304056. eCollection 2024.
3
Longitudinal study of the impact of three major regulations on the Korean pharmaceutical industry in the last 30 years.30 年来三项主要法规对韩国制药行业影响的纵向研究。
Health Res Policy Syst. 2022 Jan 6;20(1):4. doi: 10.1186/s12961-021-00797-9.
4
American export control, technology spillover and innovation of Chinese pharmaceutical Industry.美国出口管制、技术溢出与中国制药行业创新
Pak J Pharm Sci. 2017 May;30(3(Special)):1151-1155.
5
Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.社会制药创新与罕见病药物的研发和部署的替代形式。
Orphanet J Rare Dis. 2022 Sep 5;17(1):344. doi: 10.1186/s13023-022-02476-6.
6
A comprehensive study on Industry 4.0 in the pharmaceutical industry for sustainable development.关于制药行业可持续发展的工业 4.0 的综合研究。
Environ Sci Pollut Res Int. 2023 Aug;30(39):90088-90098. doi: 10.1007/s11356-023-26856-y. Epub 2023 May 2.
7
[Thoughts of the combination of medicine and engineering and collaborative innovation on surgery in China].[关于中国医学与工程学结合及外科领域协同创新的思考]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jun 25;23(6):562-565. doi: 10.3760/cma.j.cn.441530-20200331-00174.
8
Has the consistency evaluation policy of generic drugs promoted the innovation quality of Chinese pharmaceutical manufacturing industry? An empirical study based on the difference-in-differences model.仿制药一致性评价政策是否提升了中国制药制造业的创新质量？基于双重差分模型的实证研究。
Front Public Health. 2023 Dec 1;11:1265756. doi: 10.3389/fpubh.2023.1265756. eCollection 2023.
9
How Technological Innovation Affect China's Pharmaceutical Smart Manufacturing Industrial Upgrading.技术创新如何影响中国制药智能制造产业升级。
J Healthc Eng. 2021 Nov 26;2021:3342153. doi: 10.1155/2021/3342153. eCollection 2021.
10
Evolutionary Path and Innovative Development of Pharmaceutical Industrial Cluster-A Case Study of Shijiazhuang, China.医药产业集群的演进路径与创新发展——以中国石家庄为例。
Int J Environ Res Public Health. 2022 Mar 2;19(5):2928. doi: 10.3390/ijerph19052928.
本文引用的文献
1
GLP1 Receptor Agonists-Effects beyond Obesity and Diabetes.GLP1 受体激动剂——超越肥胖和糖尿病的作用。
Cells. 2023 Dec 28;13(1):65. doi: 10.3390/cells13010065.
2
Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations.设计和开展适应性试验以评估卫生服务干预措施及实施研究：实际考量
BMJ Med. 2022;1(1). doi: 10.1136/bmjmed-2022-000158. Epub 2022 Jul 1.
3
The triple win - implementation science benefits patients, healthcare systems and industry alike.三赢——实施科学使患者、医疗保健系统和行业均受益。
J Comp Eff Res. 2022 Jun;11(9):639-642. doi: 10.2217/cer-2022-0058. Epub 2022 Apr 28.
4
Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review.新药品在临床实践中的采用的障碍和促进因素：系统评价。
BMC Health Serv Res. 2021 Nov 5;21(1):1198. doi: 10.1186/s12913-021-07196-4.
5
The influence of contextual factors on healthcare quality improvement initiatives: a realist review.语境因素对医疗质量改进措施的影响：一个现实主义的综述。
Syst Rev. 2020 Apr 26;9(1):94. doi: 10.1186/s13643-020-01344-3.
6
An introduction to implementation science for the non-specialist.非专业人士实施科学概论。
BMC Psychol. 2015 Sep 16;3(1):32. doi: 10.1186/s40359-015-0089-9.
Zotero 插件